Cardiovascular effects of smoking

G. Mancia, A. Groppelli, R. Casadei, S. Omboni, E. Mutti, G. Parati

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Coronary heart disease (CHD) increases with smoking and this factor interacts with hypercholesterolemia and hypertension in raising the incidence of this condition in a greater than linear fashion. This can be explained by the adverse effect of smoking on plasma fibrogen, platelet turnover and lipid profile. It may also be accounted for, however, by the acute bradycardia, increase in blood pressure and generalized vasoconstriction accompanying smoking, due to a nicotine-dependent activation of the sympathetic nervous system. These effects (which in heavy smokers can raise blood pressure permanently) are only partly offset by beta-blockers and can only be abolished by opposing the cardiac and vascular sympathetic influences by alpha and beta-blockade combined.

Original languageEnglish
Pages (from-to)917-929
Number of pages13
JournalClinical and Experimental Hypertension
VolumeA12
Issue number5
DOIs
Publication statusPublished - 1990

Fingerprint

Smoking
Blood Pressure
Sympathetic Nervous System
Bradycardia
Hypercholesterolemia
Vasoconstriction
Nicotine
Coronary Disease
Blood Vessels
Blood Platelets
Hypertension
Lipids
Incidence

Keywords

  • Blood pressure
  • Cardioprotection
  • Coronary circulation
  • Coronary heart disease
  • Smoking
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology

Cite this

Mancia, G., Groppelli, A., Casadei, R., Omboni, S., Mutti, E., & Parati, G. (1990). Cardiovascular effects of smoking. Clinical and Experimental Hypertension, A12(5), 917-929. https://doi.org/10.3109/10641969009073509

Cardiovascular effects of smoking. / Mancia, G.; Groppelli, A.; Casadei, R.; Omboni, S.; Mutti, E.; Parati, G.

In: Clinical and Experimental Hypertension, Vol. A12, No. 5, 1990, p. 917-929.

Research output: Contribution to journalArticle

Mancia, G, Groppelli, A, Casadei, R, Omboni, S, Mutti, E & Parati, G 1990, 'Cardiovascular effects of smoking', Clinical and Experimental Hypertension, vol. A12, no. 5, pp. 917-929. https://doi.org/10.3109/10641969009073509
Mancia, G. ; Groppelli, A. ; Casadei, R. ; Omboni, S. ; Mutti, E. ; Parati, G. / Cardiovascular effects of smoking. In: Clinical and Experimental Hypertension. 1990 ; Vol. A12, No. 5. pp. 917-929.
@article{116d25aeeabd415fbd685abec7ca1457,
title = "Cardiovascular effects of smoking",
abstract = "Coronary heart disease (CHD) increases with smoking and this factor interacts with hypercholesterolemia and hypertension in raising the incidence of this condition in a greater than linear fashion. This can be explained by the adverse effect of smoking on plasma fibrogen, platelet turnover and lipid profile. It may also be accounted for, however, by the acute bradycardia, increase in blood pressure and generalized vasoconstriction accompanying smoking, due to a nicotine-dependent activation of the sympathetic nervous system. These effects (which in heavy smokers can raise blood pressure permanently) are only partly offset by beta-blockers and can only be abolished by opposing the cardiac and vascular sympathetic influences by alpha and beta-blockade combined.",
keywords = "Blood pressure, Cardioprotection, Coronary circulation, Coronary heart disease, Smoking, Sympathetic nervous system",
author = "G. Mancia and A. Groppelli and R. Casadei and S. Omboni and E. Mutti and G. Parati",
year = "1990",
doi = "10.3109/10641969009073509",
language = "English",
volume = "A12",
pages = "917--929",
journal = "Clinical and Experimental Hypertension",
issn = "1064-1963",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Cardiovascular effects of smoking

AU - Mancia, G.

AU - Groppelli, A.

AU - Casadei, R.

AU - Omboni, S.

AU - Mutti, E.

AU - Parati, G.

PY - 1990

Y1 - 1990

N2 - Coronary heart disease (CHD) increases with smoking and this factor interacts with hypercholesterolemia and hypertension in raising the incidence of this condition in a greater than linear fashion. This can be explained by the adverse effect of smoking on plasma fibrogen, platelet turnover and lipid profile. It may also be accounted for, however, by the acute bradycardia, increase in blood pressure and generalized vasoconstriction accompanying smoking, due to a nicotine-dependent activation of the sympathetic nervous system. These effects (which in heavy smokers can raise blood pressure permanently) are only partly offset by beta-blockers and can only be abolished by opposing the cardiac and vascular sympathetic influences by alpha and beta-blockade combined.

AB - Coronary heart disease (CHD) increases with smoking and this factor interacts with hypercholesterolemia and hypertension in raising the incidence of this condition in a greater than linear fashion. This can be explained by the adverse effect of smoking on plasma fibrogen, platelet turnover and lipid profile. It may also be accounted for, however, by the acute bradycardia, increase in blood pressure and generalized vasoconstriction accompanying smoking, due to a nicotine-dependent activation of the sympathetic nervous system. These effects (which in heavy smokers can raise blood pressure permanently) are only partly offset by beta-blockers and can only be abolished by opposing the cardiac and vascular sympathetic influences by alpha and beta-blockade combined.

KW - Blood pressure

KW - Cardioprotection

KW - Coronary circulation

KW - Coronary heart disease

KW - Smoking

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0025341259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025341259&partnerID=8YFLogxK

U2 - 10.3109/10641969009073509

DO - 10.3109/10641969009073509

M3 - Article

VL - A12

SP - 917

EP - 929

JO - Clinical and Experimental Hypertension

JF - Clinical and Experimental Hypertension

SN - 1064-1963

IS - 5

ER -